HEXO Stock: Is the Cannabis Giant a Buy Right Now?

Down 95% from all-time highs, HEXO stock continues to remain a high-risk bet for growth investors.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Shares of Canadian cannabis giant HEXO (TSX:HEXO)(NASDAQ:HEXO) rose by over 10% in the first half of 2021. However, since then, the stock has wiped off these gains and is now down over 50% year to date. The cannabis stock is now down 95% from record highs, burning significant investor wealth in the process.

Generally, you look at a company’s revenue and earnings growth to make an investment decision. But it’s difficult for cannabis companies to keep delivering top-line growth and earnings improvement, as the industry is grappling with a wide array of structural issues. Further, the cannabis industry is at a nascent stage, which has attracted several players, thereby increasing competition resulting in a price war to capture market share.

So, marijuana producers, including HEXO, have been hit by widening losses, which have led to multiple equity capital raises in the past, resulting in an accelerated dilution of shareholder wealth in recent years.

Investors also need to consider a company’s cash flow from operations to see if the entity is burning through cash with respect to day-to-day activities, which will then result in further shareholder dilution and a corresponding decline in stock price. For example, in August 2021, HEXO stock lost over 25% in a single trading session after the company announced its plan to raise over $175 million via an equity offering.

HEXO stock remains vulnerable

In the last 12 months, HEXO has burnt close to $20 million to fund its operational activities. In its fiscal third quarter of 2021 (ended in July), HEXO reported a cash balance of $194 million, which provides the company with enough leeway to improve its cash flows in the future. However, HEXO has been on an acquisition spree this year and disclosed three big-ticket acquisitions in the first five months of 2021. These acquisitions will be funded via a combination of company stock and cash, both of which will weigh on HEXO’s already weak financials.

Investors who are bullish on HEXO stock will argue that the company’s acquisition of Redecan, which is the largest privately held cannabis producer in Canada, will allow the former to gain significant traction in Canada’s recreational marijuana market. But can HEXO afford to keep raising capital and fund its expansion plans?

Similar to other Canadian cannabis producers, HEXO is also eyeing expansion south of the border for when pot is legalized at the federal level. A few months back, HEXO acquired a cannabis facility in Colorado for $6 million. But it will spend around $50 million to upgrade the facility, which is a matter of grave concern.

What’s next for HEXO stock?

HEXO is currently valued at a market cap of $603 million. The company has increased its revenue from just $4.9 million in fiscal 2018 to $80.78 million in fiscal 2020. But its operating losses have also widened from $17.9 million to $163 million in this period. If interest rates rise, it will negatively impact HEXO’s balance sheet, as the company has already paid $11 million in interest and financing expenses in the last 12 months, accounting for almost 10% of total sales in this period.

HEXO might continue to raise debt to fund its acquisition plans, which suggest the marijuana company has to reduce cash burn at a rapid clip to gain investor confidence. Despite the company’s less-than-impressive financials, Bay Street expects HEXO stock to more than double to $5.51 per share in the next 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »